Phenotypic spectrum of autosomal recessive retinitis pigmentosa without posterior column ataxia caused by mutations in the FLVCR1 gene

2019 ◽  
Vol 257 (3) ◽  
pp. 629-638 ◽  
Author(s):  
Laura Kuehlewein ◽  
Ludger Schöls ◽  
Pablo Llavona ◽  
Alexander Grimm ◽  
Saskia Biskup ◽  
...  

Neurology ◽  
1998 ◽  
Vol 51 (6) ◽  
pp. 1772-1773 ◽  
Author(s):  
J. Berciano ◽  
J. M. Polo




Neurology ◽  
1997 ◽  
Vol 49 (6) ◽  
pp. 1717-1720 ◽  
Author(s):  
J. J. Higgins ◽  
D. H. Morton ◽  
N. Patronas ◽  
L. E. Nee


Neurology ◽  
1998 ◽  
Vol 51 (6) ◽  
pp. 1773-1773
Author(s):  
J. J. Higgins


2014 ◽  
Vol 125 (1) ◽  
pp. 43-49 ◽  
Author(s):  
Aziz Shaibani ◽  
Lee-Jun Wong ◽  
Victor Wei Zhang ◽  
Richard Alan Lewis ◽  
Marwan Shinawi


Neurogenetics ◽  
2021 ◽  
Author(s):  
Katja Kloth ◽  
Bernarda Lozic ◽  
Julia Tagoe ◽  
Mariëtte J. V. Hoffer ◽  
Amelie Van der Ven ◽  
...  

AbstractANK3 encodes multiple isoforms of ankyrin-G, resulting in variegated tissue expression and function, especially regarding its role in neuronal development. Based on the zygosity, location, and type, ANK3 variants result in different neurodevelopmental phenotypes. Autism spectrum disorder has been associated with heterozygous missense variants in ANK3, whereas a more severe neurodevelopmental phenotype is caused by isoform-dependent, autosomal-dominant, or autosomal-recessive loss-of-function variants. Here, we present four individuals affected by a variable neurodevelopmental phenotype harboring a heterozygous frameshift or nonsense variant affecting all ANK3 transcripts. Thus, we provide further evidence of an isoform-based phenotypic continuum underlying ANK3-associated pathologies and expand its phenotypic spectrum.



2021 ◽  
pp. 1-8
Author(s):  
Moustafa Magliyah ◽  
Abdulaziz A. Alshamrani ◽  
Patrik Schatz ◽  
Ibrahim Taskintuna ◽  
Yahya Alzahrani ◽  
...  


2021 ◽  
Vol 22 (12) ◽  
pp. 6523
Author(s):  
Adrian Cordido ◽  
Marta Vizoso-Gonzalez ◽  
Miguel A. Garcia-Gonzalez

Autosomal recessive polycystic kidney disease (ARPKD) is a rare disorder and one of the most severe forms of polycystic kidney disease, leading to end-stage renal disease (ESRD) in childhood. PKHD1 is the gene that is responsible for the vast majority of ARPKD. However, some cases have been related to a new gene that was recently identified (DZIP1L gene), as well as several ciliary genes that can mimic a ARPKD-like phenotypic spectrum. In addition, a number of molecular pathways involved in the ARPKD pathogenesis and progression were elucidated using cellular and animal models. However, the function of the ARPKD proteins and the molecular mechanism of the disease currently remain incompletely understood. Here, we review the clinics, treatment, genetics, and molecular basis of ARPKD, highlighting the most recent findings in the field.



2010 ◽  
Vol 87 (5) ◽  
pp. 643-654 ◽  
Author(s):  
Anjali M. Rajadhyaksha ◽  
Olivier Elemento ◽  
Erik G. Puffenberger ◽  
Kathryn C. Schierberl ◽  
Jenny Z. Xiang ◽  
...  


Sign in / Sign up

Export Citation Format

Share Document